Cellserve GmbH
The Solution
The Solution
Introducing CardAPcells
Development of a curative, less invasive cell therapy for heart insufficiency:
The first curative treatment for regeneration of the diseased heart tissue and an extension of the lifetime will be possible.
Current therapies can maintain the current state of the damaged heart at best without actual improvement.
With CardAPCells, the pumping power of a weakened heart muscle can be strengthend, so that heart failure or heart transplantation can be avoided.
Heart Transplantation
- Expensive
- Highly invasive
- Subjects patients to many unpredictable risks and complications
Drug Therapy
- Does not cure a heart condition
- Mere attempt to halt progression
- Patients keep their heart damages
Our patented cell therapy combines the best of both current approaches!
CardAPCells Therapy
- Cheaper than heart transplantation
- Minimally invasive
- Fewer risks of complications
- Truly curative